Skip to main content
. 2017 Dec 8;9(2):2866–2875. doi: 10.18632/oncotarget.23165

Figure 5. Progress free survival in patients with different risk factors in surgery and non-surgery groups.

Figure 5

(AD) represent PFS for patients with parametrical invasion, pelvic lymph node metastases, residual disease and tumor diameter > 4 cm, respectively.